$142.24
N/A
Ult. Agg.: Nov 11, 4:00 PM
Encompass Health rose 23.9% from $114.80 to $142.24, ahead of the S&P 500's +11.2%. Its worst day was Mar 11 (−5.9%), and its low came Feb 2 at $93.83.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $1.46 beat the $1.30 estimate on $1.5B revenue (est. $1.5B); FY revenue guidance of $6.4B–$6.5B against the $6.4B consensus.
+5.9%, on 3M shares, the year's heaviest volume · S&P 500 +1.9%
Story events cover the past 12 months · Times ET
Encompass Health shares fell 5.9%, while the S&P 500 fell 0.1%.
−5.9%, the year's worst day · S&P 500 −0.1%
Encompass Health shares rose 8.0%, while the S&P 500 rose 0.5%.
+8.0% · S&P 500 +0.5%
EPS of $1.60 beat the $1.50 estimate on $1.6B revenue (est. $1.6B); FY revenue guidance of $6.4B–$6.5B against the $6.4B consensus.
+7.5% · S&P 500 +0.3%
Encompass Health shares rose 5.0%, while the S&P 500 fell 0.1%.
+5.0% · S&P 500 −0.1%
EPS of $1.55 beat the $1.48 estimate on $1.6B revenue (est. $1.6B); FY revenue guidance of $6.4B–$6.5B against the $6.4B consensus.
+12.6%, the year's best day · S&P 500 −0.2%
EPS of $1.52 beat the $1.36 estimate on $1.6B revenue (est. $1.6B); FY revenue guidance of $6.5B–$6.5B against the $6.5B consensus.
+7.7% · S&P 500 −0.4%
Where it ended: a close of $142.24 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 4, 2027 (EPS est. $1.61, revenue est. $1.7B).
As of the Nov 11, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for EHC and SPY from Benzinga historical bars. Not investment advice.